With a simple click, Fundamental Charts can be shared with colleagues, downloaded as images, embedded into emails or blogs, or saved for you to revisit at any time. APT RFL WILC EHTH CPL PYDS DOMO INS ICAD VIPS 1 chrismahlmann5/1/16, 04: 33 PYDS All aboard the sucker train Dont say I didnt warn you. Des Lauriers became a senior research analyst at Craig. iCAD (Issuer) Stevens Stacey M (Reporting) Form 4 Statement of changes in beneficial ownership of securities 3:01 PM: iCAD (Filer) Form SD Specialized Disclosure Report 3:01 PM: iCAD (Filer) Form PRE 14A: 7:18 AM: iCAD (Filer) Form 10-Q General form for quarterly reports under Section 13 or 15(d) 4:05. Twitter Share Facebook Share StockTwits Share. Eric Des Lauriers joined Craig-Hallum Capital Group in 2016 as a Research Analyst focused on small and micro-cap companies within the consumer, gaming, and technology verticals. See annual and quarterly financial statements and annual report data for Icad Inc. Share your Research to Promote your Brandįundamental Charts are brandable with your firm’s logo enabling you to own your research and create additional touch points with prospects and clients. Eric Des Lauriers Senior Research Analyst (617) 275-5177. The 21.57 average price target implies an upside of 30 from the 16.55 trading price. The firm has also developed a technology namely Xoft Axxent electronic brachytherapy system used. The unanimous Strong Buy consensus rating on ICAD shares shows that Wall Street is in broad agreement with Oppenheimer’s analyst there are 7 Buy-side ratings on ICAD shares. iCAD has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 23rd, 2022 based off prior year's report dates. Fundamental Charts can be built off of more than 4,000 metrics and line items, covering 20,000+ securities and 400,000+ economic indicators such as labor statistics, GDP, and more. Description: icad Inc provides cancer detection, radiation therapy and workflow solutions, primarily computer-aided detection and workflow solutions for breast, prostate and colorectal cancers.Its products include powerlook tomo detection, powerlook density assessment, and vera look. Earnings for iCAD are expected to grow in the coming year, from (0.27) to (0.06) per share. Fundamental Analysis Save time on research by. We source data from Morningstar and S&P Global in addition to mining our own economic indicators and events data. StockTwits Read live tweets from the financial and investing community about the stock youre interested in.
YCharts enables the comparison of multiple securities based on virtually any performance metric or valuation ratio - plus, layer in macroeconomic indicators to show the “why” behind a security’s performance. Go beyond price to chart the fundamental levers that impact performance. Tell a Compelling Story Using Stunning Visuals Choose from thousands of securities and metrics to create insightful and comprehensive visuals, add your firm’s logo for marketing distribution, and share your knowledge with clients and prospects.
0 kommentar(er)
